(CHWY) Chewy - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US16679L1098
Stock: Pet Food, Pet Supplies, Pet Medications, Pet Services
Total Rating 32
Risk 37
Buy Signal -1.03
| Risk 5d forecast | |
|---|---|
| Volatility | 49.9% |
| Relative Tail Risk | -6.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.65 |
| Alpha | -41.99 |
| Character TTM | |
|---|---|
| Beta | 0.900 |
| Beta Downside | 1.994 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.01% |
| CAGR/Max DD | -0.21 |
EPS (Earnings per Share)
Revenue
Description: CHWY Chewy March 05, 2026
Chewy, Inc. (CHWY) operates as an e-commerce platform for pet products and services in the United States. The company offers a range of items including pet food, treats, supplies, medications, and health-related products.
Its business model relies on direct-to-consumer sales via retail websites and mobile applications, with a significant portion of revenue derived from its Autoship subscription program. The pet supply industry is experiencing a shift towards online retail, and subscription models help secure recurring revenue for e-commerce businesses.
Founded in 2010 and based in Plantation, Florida, Chewy operates within the Other Specialty Retail GICS sub-industry.
Further analysis of CHWYs financial performance and market position can be found on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 206.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 2.53 > 1.0 |
| NWC/Revenue: -2.64% < 20% (prev -4.92%; Δ 2.28% < -1%) |
| CFO/TA 0.19 > 3% & CFO 635.7m > Net Income 206.4m |
| Net Debt (-152.4m) to EBITDA (338.2m): -0.45 < 3 |
| Current Ratio: 0.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (425.5m) vs 12m ago -0.25% < -2% |
| Gross Margin: 29.56% > 18% (prev 0.29%; Δ 2927 % > 0.5%) |
| Asset Turnover: 402.5% > 50% (prev 387.5%; Δ 15.08% > 0%) |
| Interest Coverage Ratio: 41.10 > 6 (EBITDA TTM 338.2m / Interest Expense TTM 5.21m) |
Altman Z'' -2.10
| A: -0.10 (Total Current Assets 1.93b - Total Current Liabilities 2.26b) / Total Assets 3.29b |
| B: -0.42 (Retained Earnings -1.40b / Total Assets 3.29b) |
| C: 0.07 (EBIT TTM 214.2m / Avg Total Assets 3.13b) |
| D: -0.49 (Book Value of Equity -1.39b / Total Liabilities 2.83b) |
| Altman-Z'' Score: -2.10 = D |
Beneish M -3.17
| DSRI: 1.02 (Receivables 216.0m/193.2m, Revenue 12.58b/11.46b) |
| GMI: 0.99 (GM 29.56% / 29.18%) |
| AQI: 0.86 (AQ_t 0.10 / AQ_t-1 0.12) |
| SGI: 1.10 (Revenue 12.58b / 11.46b) |
| TATA: -0.13 (NI 206.4m - CFO 635.7m) / TA 3.29b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of CHWY shares?
As of March 06, 2026, the stock is trading at USD 26.07 with a total of 8,060,821 shares traded.
Over the past week, the price has changed by -3.34%, over one month by -1.88%, over three months by -22.11% and over the past year by -29.31%.
Over the past week, the price has changed by -3.34%, over one month by -1.88%, over three months by -22.11% and over the past year by -29.31%.
Is CHWY a buy, sell or hold?
Chewy has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy CHWY.
- StrongBuy: 11
- Buy: 6
- Hold: 12
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the CHWY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.5 | 70.5% |
| Analysts Target Price | 44.5 | 70.5% |
CHWY Fundamental Data Overview March 06, 2026
P/E Trailing = 52.0612
P/E Forward = 19.7239
P/S = 0.8413
P/B = 23.7294
P/EG = 1.022
Revenue TTM = 12.58b USD
EBIT TTM = 214.2m USD
EBITDA TTM = 338.2m USD
Long Term Debt = 523.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 33.5m USD (from shortTermDebt, last fiscal year)
Debt = 523.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -152.4m USD (from netDebt column, last quarter)
Enterprise Value = 10.41b USD (10.59b + Debt 523.0m - CCE 701.5m)
Interest Coverage Ratio = 41.10 (Ebit TTM 214.2m / Interest Expense TTM 5.21m)
EV/FCF = 21.37x (Enterprise Value 10.41b / FCF TTM 487.0m)
FCF Yield = 4.68% (FCF TTM 487.0m / Enterprise Value 10.41b)
FCF Margin = 3.87% (FCF TTM 487.0m / Revenue TTM 12.58b)
Net Margin = 1.64% (Net Income TTM 206.4m / Revenue TTM 12.58b)
Gross Margin = 29.56% ((Revenue TTM 12.58b - Cost of Revenue TTM 8.86b) / Revenue TTM)
Gross Margin QoQ = 29.78% (prev 30.35%)
Tobins Q-Ratio = 3.16 (Enterprise Value 10.41b / Total Assets 3.29b)
Interest Expense / Debt = 0.27% (Interest Expense 1.40m / Debt 523.0m)
Taxrate = 14.57% (10.1m / 69.3m)
NOPAT = 183.0m (EBIT 214.2m * (1 - 14.57%))
Current Ratio = 0.85 (Total Current Assets 1.93b / Total Current Liabilities 2.26b)
Debt / Equity = 1.11 (Debt 523.0m / totalStockholderEquity, last quarter 469.4m)
Debt / EBITDA = -0.45 (Net Debt -152.4m / EBITDA 338.2m)
Debt / FCF = -0.31 (Net Debt -152.4m / FCF TTM 487.0m)
Total Stockholder Equity = 374.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.60% (Net Income 206.4m / Total Assets 3.29b)
RoE = 55.17% (Net Income TTM 206.4m / Total Stockholder Equity 374.1m)
RoCE = 23.88% (EBIT 214.2m / Capital Employed (Equity 374.1m + L.T.Debt 523.0m))
RoIC = 48.92% (NOPAT 183.0m / Invested Capital 374.1m)
WACC = 9.11% (E(10.59b)/V(11.11b) * Re(9.55%) + D(523.0m)/V(11.11b) * Rd(0.27%) * (1-Tc(0.15)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.61%
[DCF] Terminal Value 77.52% ; FCFF base≈437.1m ; Y1≈531.8m ; Y5≈877.3m
[DCF] Fair Price = 51.47 (EV 12.12b - Net Debt -152.4m = Equity 12.28b / Shares 238.5m; r=9.11% [WACC]; 5y FCF grow 23.16% → 2.90% )
EPS Correlation: 63.47 | EPS CAGR: -9.68% | SUE: -1.76 | # QB: 0
Revenue Correlation: 94.79 | Revenue CAGR: 7.35% | SUE: 1.14 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.42 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+4 | Analysts=13
EPS next Year (2027-01-31): EPS=1.56 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+22.0% | Growth Revenue=+7.9%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.6% (Discount Rate 9.6% - Earnings Yield 1.9%)
[Growth] Growth Spread = +0.5% (Analyst 8.1% - Implied 7.6%)
P/E Forward = 19.7239
P/S = 0.8413
P/B = 23.7294
P/EG = 1.022
Revenue TTM = 12.58b USD
EBIT TTM = 214.2m USD
EBITDA TTM = 338.2m USD
Long Term Debt = 523.0m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 33.5m USD (from shortTermDebt, last fiscal year)
Debt = 523.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -152.4m USD (from netDebt column, last quarter)
Enterprise Value = 10.41b USD (10.59b + Debt 523.0m - CCE 701.5m)
Interest Coverage Ratio = 41.10 (Ebit TTM 214.2m / Interest Expense TTM 5.21m)
EV/FCF = 21.37x (Enterprise Value 10.41b / FCF TTM 487.0m)
FCF Yield = 4.68% (FCF TTM 487.0m / Enterprise Value 10.41b)
FCF Margin = 3.87% (FCF TTM 487.0m / Revenue TTM 12.58b)
Net Margin = 1.64% (Net Income TTM 206.4m / Revenue TTM 12.58b)
Gross Margin = 29.56% ((Revenue TTM 12.58b - Cost of Revenue TTM 8.86b) / Revenue TTM)
Gross Margin QoQ = 29.78% (prev 30.35%)
Tobins Q-Ratio = 3.16 (Enterprise Value 10.41b / Total Assets 3.29b)
Interest Expense / Debt = 0.27% (Interest Expense 1.40m / Debt 523.0m)
Taxrate = 14.57% (10.1m / 69.3m)
NOPAT = 183.0m (EBIT 214.2m * (1 - 14.57%))
Current Ratio = 0.85 (Total Current Assets 1.93b / Total Current Liabilities 2.26b)
Debt / Equity = 1.11 (Debt 523.0m / totalStockholderEquity, last quarter 469.4m)
Debt / EBITDA = -0.45 (Net Debt -152.4m / EBITDA 338.2m)
Debt / FCF = -0.31 (Net Debt -152.4m / FCF TTM 487.0m)
Total Stockholder Equity = 374.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.60% (Net Income 206.4m / Total Assets 3.29b)
RoE = 55.17% (Net Income TTM 206.4m / Total Stockholder Equity 374.1m)
RoCE = 23.88% (EBIT 214.2m / Capital Employed (Equity 374.1m + L.T.Debt 523.0m))
RoIC = 48.92% (NOPAT 183.0m / Invested Capital 374.1m)
WACC = 9.11% (E(10.59b)/V(11.11b) * Re(9.55%) + D(523.0m)/V(11.11b) * Rd(0.27%) * (1-Tc(0.15)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.61%
[DCF] Terminal Value 77.52% ; FCFF base≈437.1m ; Y1≈531.8m ; Y5≈877.3m
[DCF] Fair Price = 51.47 (EV 12.12b - Net Debt -152.4m = Equity 12.28b / Shares 238.5m; r=9.11% [WACC]; 5y FCF grow 23.16% → 2.90% )
EPS Correlation: 63.47 | EPS CAGR: -9.68% | SUE: -1.76 | # QB: 0
Revenue Correlation: 94.79 | Revenue CAGR: 7.35% | SUE: 1.14 | # QB: 4
EPS next Quarter (2026-04-30): EPS=0.42 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+4 | Analysts=13
EPS next Year (2027-01-31): EPS=1.56 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+22.0% | Growth Revenue=+7.9%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.6% (Discount Rate 9.6% - Earnings Yield 1.9%)
[Growth] Growth Spread = +0.5% (Analyst 8.1% - Implied 7.6%)